A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the fatal illness. Huntington’s is an inherited condition that is caused by a ...

A recent case report and literature review published in the Journal of Cosmetic Dermatology highlight a rare but concerning ...

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease characterized primarily by the formation of heterotopic ...

Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving weight-loss drug Wegrovy ...

For centuries, Thailand has produced premium silk fabrics. Now, researchers in Bangkok have found another use for the fiber: ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...

A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

From less vaccinations to physician burn-out, doctors fear the worst under Trump and Kennedy's vision for health ...